INDIANAPOLIS—Every year, more than 800,000 people in the United States experience a potentially life-threatening heart attack, or acute myocardial infarction (MI). The damage to heart muscle that occurs with MI puts many at risk of developing complications like heart failure after the event. This May, the Krannert Cardiovascular Research Center, the research engine of the IU Cardiovascular Institute, will bring more than 20 world-renowned leaders in cardiovascular research and practice to present the latest discoveries and best practices to improve the lives of patients suffering from acute MI.
The 2023 Inaugural Krannert Biennial, “Myocardial Infarction and Reperfusion Injury: New Evidence to Shift Existing Paradigms,” will be held Friday, May 12 – Saturday, May 13, 2023 at the Eiteljorg Museum, 500 W. Washington St., with hotel accommodations available at the adjacent JW Marriott. Registration is now open to everyone interested in attending this high-impact event including specialists in cardiovascular disease, interventional cardiology, cardiothoracic radiology, emergency medicine, and other health professionals dedicated to cardiovascular care.
Interactive sessions will cover:
Mechanisms of MI and Reperfusion Injury
Therapies – What Works, What Doesn’t Work and Why
Translating Innovation to Impact Diverse Communities
“The Inaugural Krannert Biennial brings together highly accomplished thought leaders from around the world to review and discuss the current knowledge and gaps in acute myocardial infarction – covering the essential basic science to active clinical trials,” said Rohan Dharmakumar, PhD, executive director of the Krannert Cardiovascular Research Center and the Charles Fisch Chair in Cardiology at IU School of Medicine. “It also provides an exciting opportunity to embed the evolving understanding of acute myocardial infarction to forge new strategies to radically change how acute myocardial infarction patients are treated and managed to improve clinical outcomes.”
The Biennial will also highlight innovative cardiovascular research and clinical trials underway at IU School of Medicine and IU Health. Recently, a study led by Dharmakumar demonstrated hemorrhage within the heart muscle following reperfusion therapy drives the formation of fatty tissue in the heart and could cause chronic heart failure in about 50 percent of heart attack survivors. A first-in-human trial is now in progress to limit this hemorrhage.
“We are excited to share our recent cardiovascular research developments with the cardiovascular community and trainees,” Dharmakumar said. “Attendees will engage with the drivers of MI science and care in a highly interactive format.”
Visiting presenters include: Valentin Fuster, MD, PhD, Mount Sinai Hospital; Gerd Heusch, MD, University of Essen, Germany; Robert Kloner, MD, PhD, Huntington Medical Research Institute; Michael Fishbein, MD, University of California, Los Angeles; Nikolaos Frangogiannis, MD, Albert Einstein College of Medicine; Andreas Kumar, MD, MS, Northern Ontario School of Medicine; Robert Gropler, MD, Washington University School of Medicine at St. Louis; Roxana Mehran, Wiener Cardiovascular Institute at Mount Sinai School of Medicine; Sunil Rao, MD, NYU Langone Health; Timothy Henry, MD, Christ Hospital Health Network; and Edward Fry, MD, Ascension.
“Clinicians, scientists and trainees will benefit from learning about the innovative cardiovascular research driven by our distinguished speakers as well as new frontiers in cardiovascular care resulting from these innovations. We are pleased to host this high-impact event designed to help us improve the cardiovascular health of those we serve through patient care and research,” said Subha V. Raman, MD, physician director of the Cardiovascular Institute, VP for Cardiovascular Services and Medtronic Zipes Chair & Chief of Cardiovascular Medicine at IU School of Medicine.
During the Krannert Biennial, the inaugural awardee of the 2023 Krannert Prize in Translational Cardiovascular Research will be announced. This award recognizes a senior scientist who has achieved international acclaim through translational cardiovascular science. The event will also feature a Young Investigator Awards Competition. A reception and dinner are planned for the evening of May 12.
IU School of Medicine has designated the biennial event for a maximum of 11.50 AMA PRA Category 1 Credits™. The medical school is jointly accredited by the Accreditation Council for Continuing Medical Education, the Accreditation Council for Pharmacy Education and the American Nursing Credentialing Center, to provide continuing education to health care professionals.
IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.